Close
Almac
Achema middle east

Priorclave Appoints New CEO for its American Operation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.
- Advertisement -

Leading British autoclave specialist Priorclave is delighted to announce their appointment of Barbra Wells as President and CEO to head up its American operation.    

She joined the North American organisation three years ago, predominantly in a marketing role and has been instrumental in driving the growth of the company in the States.

For this leading British autoclave design and manufacturing specialist Priorclave, America is rapidly becoming one of its major overseas success stories. For cultural, regulatory, and practical reasons, North America had proven a challenging market, however during more recent years Priorclave North America has been instrumental in overcoming these obstacles and educating customers as to the notable savings they can gain-in reduced energy, water, and maintenance costs-by adopting a proper research-grade laboratory autoclave.

Priorclave’s cylindrical laboratory and research autoclave ranges, built to ASME standard in the UK factory, are in particular achieving considerable attention in the States due to their over efficiencies.

Commenting Barbra says, ““The US continues to be a strong market for the Priorclave brand of autoclaves because our ‘on-demand’ steam sterilizers are designed for research laboratories, not 24-hour medical operation. Much of our success revolves around the reliability, sustainability, and flexibility of these leading British designed autoclaves. These are overriding benefits that drive our success because laboratory budgets are an issue here in America, particularly in the education sector where every dollar is counted.“

Barbra is delighted and eager to take the helm of a company that’s leading the way in lab efficiency in North America.

Latest stories

Related stories

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Samsung Biologics to Buy US Drug Plant from GSK for $280M

On December 22, 2025, the news has been confirmed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »